Generic Drug Marketplace
Dr. Janet Woodcock testified at a hearing on the review and approval process for generic prescription drugs. She also addressed senators' co… read more
Dr. Janet Woodcock testified at a hearing on the review and approval process for generic prescription drugs. She also addressed senators' concerns over the lack of generic alternatives for certain brand name medicines, specifically pharmaceutical manufacturer Mylan’s EpiPen, an anti-anaphylaxis injection medication for which the company was criticized for raising the price 500 percent over a seven-year period. close
People in this video
-
Janet Woodcock M.D. Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research
Hosting Organization
Related Video
-
News of the Day
An update on news of the day included an investigation into pharmaceutical price-fixing.
-
Prescription Drug Market
Chief executive officers (CEOs) of several pharmaceutical companies and two Food and Drug Administration (FDA) officials…
-
Generic Drug Approval Process and Accessibility
Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, testified at a hearing on the accessi…
-
FDA Fiscal Year 2018 Budget
Commissioner Scott Gottlieb testified before a Senate Appropriations subcommittee on the President Trump’s fiscal year 2…